Buprenorphine Treatment for Adolescents and Young Adults With Opioid Use Disorders: A Narrative Review

被引:50
|
作者
Borodovsky, Jacob T. [1 ,2 ]
Levy, Sharon [3 ,4 ]
Fishman, Marc [5 ,6 ]
Marsch, Lisa A. [1 ]
机构
[1] Dartmouth Geisel Sch Med, Ctr Technol & Behav Hlth, Lebanon, NH USA
[2] Dartmouth Geisel Sch Med, Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA
[3] Boston Childrens Hosp, Adolescent Substance Abuse Program, Boston, MA USA
[4] Harvard Med Sch, Dept Pediat, Boston, MA USA
[5] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA
[6] Maryland Treatment Ctr, Baltimore, MD USA
关键词
adolescents; buprenorphine; opioid use disorder; treatment; young adults; MEDICATION-ASSISTED TREATMENT; RANDOMIZED CONTROLLED-TRIAL; HEROIN USE; DEPENDENT ADOLESCENTS; TREATMENT OUTCOMES; SUBSTANCE-ABUSE; MAINTENANCE TREATMENT; PRESCRIPTION OPIOIDS; NONMEDICAL USE; DRUG-ABUSE;
D O I
10.1097/ADM.0000000000000388
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
In the past decade, a new cohort of adolescents and young adults with opioid use disorders (OUD) has emerged. While medications and psychosocial treatments are available, few adolescents and young adults with OUD can access and remain in treatment. Effective, practical, and scalable treatment paradigms for this young population are needed. Buprenorphine is a medication with unique pharmacological and regulatory characteristics that make it a promising component of adolescent and young adult OUD treatment models. Three randomized controlled trials and multiple observational studies have evaluated the use of buprenorphine to treat this population. However, data from these studies have not been consolidated into an up-to-date summary that may be useful to clinicians. The objective of this narrative review is to inform clinical practice by summarizing results of primary and secondary analyses from randomized controlled clinical trials and observational studies that have evaluated the use of buprenorphine to treat adolescents and young adults with OUD. Based on results from these studies, we encourage the conceptualization of OUD among youth as a chronic medical condition requiring a long-term management strategy. This includes treatment with buprenorphine in conjunction with medication-prescribing protocols that do not necessarily require daily clinic attendance for observed medication adherence. However, more study of treatment delivery models, addressing such issues as medication adherence and intensity requirements, is needed to determine practices that optimize outcomes for youth.
引用
收藏
页码:170 / 183
页数:14
相关论文
共 50 条
  • [1] Effectiveness of and Access to Medications for Opioid Use Disorder for Adolescents and Young Adults: A Scoping Review
    McCarty, Dennis
    Chan, Brian
    Buchheit, Bradley M.
    Bougatsos, Christina
    Grusing, Sara
    Chou, Roger
    JOURNAL OF ADDICTION MEDICINE, 2022, 16 (03) : E157 - E164
  • [2] Treatment of Opioid-Dependent Adolescents and Young Adults With Buprenorphine
    Subramaniam, Geetha A.
    Fishman, Marc J.
    Woody, George
    CURRENT PSYCHIATRY REPORTS, 2009, 11 (05) : 360 - 363
  • [3] Treatment of opioid-dependent adolescents and young adults with buprenorphine
    Geetha A. Subramaniam
    Marc J. Fishman
    George Woody
    Current Psychiatry Reports, 2009, 11 : 360 - 363
  • [4] Initiation of opioid agonist treatment and subsequent substance use and other patterns among adolescents and young adults in Vancouver, Canada
    Pilarinos, Andreas
    Fast, Danya
    Nosova, Ekaterina
    Kwa, Yandi
    Joe, Ronald
    Buxton, Jane A.
    DeBeck, Kora
    DRUG AND ALCOHOL DEPENDENCE, 2022, 235
  • [5] Sex-based differences in psychiatric symptoms and opioid abstinence during buprenorphine/naloxone treatment in adolescents with opioid use disorders
    Hammond, Christopher J.
    Park, Grace
    Kady, Annabel
    Rathod, Krutika
    Rahman, Naisa
    Vidal, Carol
    Wenzel, Kevin
    Fishman, Marc
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2022, 133
  • [6] Illicit use of methadone and buprenorphine among adolescents and young adults in Sweden
    Richert, Torkel
    Johnson, Bjorn
    HARM REDUCTION JOURNAL, 2013, 10
  • [7] Buprenorphine-naloxone treatment responses differ between young adults with heroin and prescription opioid use disorders
    Romero-Gonzalez, Mauricio
    Shahanaghi, Abtin
    DiGirolamo, Gregory J.
    Gonzalez, Gerardo
    AMERICAN JOURNAL ON ADDICTIONS, 2017, 26 (08): : 838 - 844
  • [8] A randomized controlled trial of buprenorphine taper duration among opioid-dependent adolescents and young adults
    Marsch, Lisa A.
    Moore, Sarah K.
    Borodovsky, Jacob T.
    Solhkhah, Ramon
    Badger, Gary J.
    Semino, Shelby
    Jarrett, Kate
    Condon, Kathleen DiGangi
    Rossettie, Kate
    Vincent, Phillip
    Hajizadeh, Neda
    Ducat, Elizabeth
    ADDICTION, 2016, 111 (08) : 1406 - 1415
  • [9] A scoping review of interventions for engaging adolescents and young adults in opioid use disorder treatment across the care cascade
    Miller, Sarah J.
    Harrison, Sayward E.
    Harrod, Steven B.
    Hills, Kimberly J.
    Litwin, Alain
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2025,
  • [10] Illicit use of methadone and buprenorphine among adolescents and young adults in Sweden
    Torkel Richert
    Björn Johnson
    Harm Reduction Journal, 10